Pure Global
NCT06418165

Vienna Hypothermic Oxygenated Machine Perfusion Study

Vienna Hypothermic Oxygenated Machine Perfusion for Liver Transplantation Study
Medical University of Vienna·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
End Stage Liver Disease,Hepatocellular Carcinoma
Study type
Observational
Sponsor & location
Primary sponsor
Medical University of Vienna
Location
Vienna, Austria
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2018
End date
Dec 31, 2038
Enrollment
500 participants
Primary outcome

Incidence of ischemic-type biliary lesions

Summary

In this observational cohort study data on all patients undergoing liver transplantation
 after hypothermic oxygenated machine perfusion at Medical University of Vienna will be
 prospectively recorded. Investigation of short- and long-term outcome in this cohort will be
 conducted.

ICD-10 classifications
Malignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver cell carcinomaToxic liver disease with hepatitis, not elsewhere classifiedDiseases of liverToxic liver disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06418165
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06418165 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Vienna and is currently Recruiting. The study focuses on End Stage Liver Disease,Hepatocellular Carcinoma. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.